The unique story behind the discovery of a natural compound with the potential to trigger humans’ dormant powers of regeneration will be the subject of The President’s Distinguished Lecture, “Unlocking Our Regenerative Power: Nature’s Regeneration Drug,” to be delivered on Wednesday, July 18, by Kevin Strange, Ph.D., president of the MDI Biological Laboratory.
The MDI Biological Laboratory has announced the establishment of the William Procter Scientific Innovation Fund in honor of Dr. William Procter (1873-1951), a businessman, entrepreneur and scientist. Procter’s seven-part “Biological Survey of the Mount Desert Region,” published between 1927 and 1946, has been an invaluable resource for biologists studying the fauna of the Mount Desert region.
The board of trustees and staff of the MDI Biological Laboratory are pleased to announce that Hermann Haller, M.D., has been named the next president of the 120-year-old research institution. Haller will begin his appointment on July 26, 2018.
New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy also plays a role in peripheral neuropathy caused by diabetes.
Coagulation Sciences LLC, a medical device startup that is being incubated at the MDI Biological Laboratory in Bar Harbor, Maine, has announced that it has selected Enercon Technologies of Gray, Maine, to be its contract manufacturing partner for its Multiple Coagulation Test SystemTM (MCTS).
Neuroscientist Andrea R. Tilden, Ph.D., is spending her sabbatical year from her position as the J. Warren Merrill Associate Professor of Biology at Colby College in Waterville, Maine, as a visiting scientist in comparative genomics at the MDI Biological Laboratory.